New partnership: Biotechgate and AdvaMed

Venture Valuation/Biotechgate and AdvaMed Team Up to Drive MedTech Industry Growth

New partnership: Biotechgate and AdvaMed

Media Release

Zurich, Switzerland and Washington, D.C., USA, August 2023 – Biotechgate, a global business development and licensing database for the life sciences industry, is proud to announce its strategic partnership with the Advanced Medical Technology Association (AdvaMed). This collaboration aims to strengthen the data integration in Biotechgate, while enhancing the visibility and insight into the thriving medtech industry.

As a key initiative of this new alliance, AdvaMed is supporting Biotechgate’s USA Life Sciences Database ( along with other partners. The database serves as a comprehensive platform where AdvaMed’s more than 400 members, ranging from large medical technology companies to small medical device innovators, will be publicly visible. This will further expand their reach and connectivity within the industry.

The life sciences database Biotechgate, as part of its commitment to support AdvaMed, will contribute further data on the medtech industry. The data will enrich the global platform as well as USA Life Sciences database with valuable resources and industry trends. As a service to AdvaMed, Biotechgate will also provide an annual Trend Analysis Report, offering in-depth analysis and statistics on the medtech industry to aid in strategic decision-making.

“We are thrilled to establish this collaborative partnership with AdvaMed,” stated Dr. Patrik Frei, CEO and Founder of Venture Valuation/Biotechgate. “By combining our expertise and resources, we aim to facilitate networking opportunities and promote the overall advancement of the medtech sector. The synergy between Biotechgate and AdvaMed will pave the way for enhanced data integration, global industry visibility, and valuable insights that aim to benefit all stakeholders. We are also looking forward to promoting AdvaMed’s annual conference, The MedTech Conference, on October 9-11, 2023 in Anaheim.”

“We are excited to partner with Venture Valuation/Biotechgate to support the USA Life Science Database. The medtech industry is at the forefront of life-saving and life-changing health care innovation, with our small companies leading the way in developing the next generation of medical technology. Ensuring these early-stage startups, and even more established medtech leaders, have access to resources and investment opportunities will allow us to better serve our industry as we work to get these products into the hands of patients who need them,” said Scott Whitaker, President and Chief Executive Officer of AdvaMed.

To browse comprehensive profiles of AdvaMed’s members, visit the USA Life Sciences Database at:

About Biotechgate:

Biotechgate is a leading business development and licensing database for the entire life science industry, offering a wealth of information on over 68,000 life science company profiles. Thanks to its unique data sourcing process, the profiles include company descriptions, contact information, product pipeline information, financing rounds, and management details, making it an invaluable resource for Medtech, pharma, start-ups, investors, and other industry professionals. Biotechgate also features 30,000 licensing deals and a clinical trials database containing over 800,000 records from registries around the world.

About AdvaMed:

AdvaMed is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. With a mission to improve patient access to safe, effective and innovative medical technologies, AdvaMed plays a pivotal role in advocating for policies that promote the highest ethical standards, appropriate reimbursement, and access to international markets.
The association supports its members through networking, education, and advocacy, driving collaboration and innovation in the healthcare industry.